Life sciences briefing: Friday, Sept. 21, 2007
Featured companies: CG Therapeutics, Complete Genomics, ConforMIS, Flexible Medical Systems, LeMaitre Vascular, MAP Pharmaceuticals, ParaPro, Vascular Architects, Zars Pharma
(UPDATED on 10/1/07: See below.)
[NOTE: Posting has been slow recently for personal reasons. I'll be doing my best to catch up today.]
Complete Genomics raises funding for high-speed sequencing — Complete Genomics, a Mountain View, Calif., developer of high-speed genome sequencing technology, said it raised an undisclosed sum in a second funding round, VentureWire reports (subscription required). The company said… Continue Reading
Topical drug maker Zars files for $86M IPO
Zars, a Salt Lake City maker of topical drugs, filed to raise up to $86.25 million in an initial offering. Its registration statement with the SEC is here, and its press release is here.
Zars specializes in topically administered drugs. It makes two dermatological anesthetics, neither of which is on the market yet. Another patch-based heat treatment for arthritis of the knee is in late-stage clinical trials, although the company doesn’t sound too optimistic about it:
ThermoProfen… Continue Reading